Infection and Immunity, November 2001, p. 7194-7196, Vol. 69, No. 11
Institut für Hygiene und
Infektionskrankheiten der Tiere, Justus-Liebig-Universität
Giessen, D-35392 Giessen, Germany
Received 2 January 2001/Returned for modification 15 March
2001/Accepted 11 July 2001
Clostridium perfringens mutant strain 121A/91 shows
neither enzymatic (phospholipase C) nor hemolytic activity.
Nevertheless, the cpa gene and the corresponding
alpha-toxin variant are detectable. Vaccination with this genetically
constructed alpha-toxin variant, rAT121/91, induces antibodies capable
of significantly reducing activities induced by wild-type toxin. Thus,
rAT121/91 could be a useful vaccine candidate.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.11.7194-7196.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Naturally Occurring Clostridium
perfringens Nontoxic Alpha-Toxin Variant as a Potential Vaccine
Candidate against Alpha-Toxin-Associated Diseases
and
*
Corresponding author. Mailing address: Institut
für Hygiene und Infektionskrankheiten der Tiere,
Justus-Liebig-Universität Giessen, Frankfurter Straße 85-87,
D-35392 Giessen, Germany. Phone: 0049/641/9938307. Fax:
0049/641/9938309. E-mail:
Heike.Schoepe{at}vetmed.uni-giessen.de.
Present address: Institut für Mikrobiologie und Tierseuchen,
Freie Universität Berlin, D-10115 Berlin, Germany.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|